1Celli B R,MacNee W,Agusti A,et al. Standards for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper. Eur Respir J,2004,23 ( 6 ) : 932 - 946.
2Seemungal TA, Donaldson GC, Bhowmik A et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med,2000,161:1608 - 1613.
3PauwelsRA, BuistAS, CalvedeyPMA, et al. On behalf of the GOLD Seientific Committee Global strategy for the diagnosis management, and prevention of chronic obstructive for Chronic Obstructive lung Disease(GOLD) Work shop summary. Am J Respir Crit Care Med, 2001,163:1256 - 1267.
6Zanini A,Chetta A,Saetta M,et al.Bronchial vascular remodelling in patients with COPD and its relationship with inhaled steroid treatment.Thorax,2009,64(12):1019-1024.
7Sears MR.Is it safe to use long-acting beta-agonists in asthma and chronic obstructive pulmonary disease? Implications of recent trials and meta-analyses.Pol Arch Med Wewn,2008,118(12):761-766.
8Hanania NA.The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.Pulm Pharmacol Ther,2008,21 (3):540-550.
9Pauwels RA,Buist AS,Calverley PM,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease.NHL BI/WHO Global Initiative for Chronic Obstructive Lung Dise ase (GOLD) Workshop summary.Am J Respir Crit Care Med,2001,163 (5):1256-1276.
10Mahler DA,Wire P,Horstman D,et al.Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease.Am J Respir Grit Care Med,2002,166 (8):1084-1091.
